Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,659 | -9,129 | -27,781 | -11,789 | -5,300 |
| Depreciation Amortization | 661 | 335 | 1,680 | 1,355 | 929 |
| Accounts receivable | 399 | 323 | 109 | 130 | 296 |
| Accounts payable and accrued liabilities | -386 | 854 | -4,757 | -4,193 | -4,319 |
| Other Working Capital | -160 | 1,019 | -3,971 | -3,461 | -3,574 |
| Other Operating Activity | 3,337 | 2,768 | 11,395 | -943 | -3,164 |
| Operating Cash Flow | $-9,808 | $-3,830 | $-23,325 | $-18,901 | $-15,132 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 367 | N/A | N/A |
| PPE Investments | -215 | -24 | 73 | 337 | 123 |
| Other Investing Activity | 0 | 0 | -1,372 | -1,372 | -1,372 |
| Investing Cash Flow | $-215 | $-24 | $-932 | $-1,035 | $-1,249 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -33 | N/A | -117 | -87 | -57 |
| Common Stock Issued | 15,807 | N/A | 13,848 | 13,848 | 13,848 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,118 | N/A |
| Other Financing Activity | -5,927 | 0 | -1,545 | -427 | -1,545 |
| Financing Cash Flow | $9,847 | $N/A | $12,186 | $12,216 | $12,246 |
| Beginning Cash Position | 11,132 | 11,132 | 23,203 | 23,203 | 23,203 |
| End Cash Position | 10,956 | 7,278 | 11,132 | 15,483 | 19,068 |
| Net Cash Flow | $-176 | $-3,854 | $-12,071 | $-7,720 | $-4,135 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,808 | -3,830 | -23,325 | -18,901 | -15,132 |
| Capital Expenditure | -215 | -24 | -281 | -17 | N/A |
| Free Cash Flow | -10,023 | -3,854 | -23,606 | -18,918 | -15,132 |